Literature DB >> 15585220

Macrophage migration inhibitory factor induces MMP-9 expression: implications for destabilization of human atherosclerotic plaques.

Yao-Zhong Kong1, Xiyong Yu, Jia-Ju Tang, Xiaosen Ouyang, Xiao-Ru Huang, Gunter Fingerle-Rowson, Michael Bacher, Larry A Scher, Richard Bucala, Hui Y Lan.   

Abstract

Macrophage migration inhibitory factor (MIF) has been shown to participate in both experimental and human atherogenesis. Expression of MMP-9 has been shown to play a role in the instability of atherosclerotic plaque. Thus, we hypothesize that MIF may participate in the destabilization of atherosclerotic plaques by stimulating MMP-9 expression. This hypothesis was investigated by examining the expression of MIF and MMP-9 in human atherosclerotic plaques using two-color immunostaining and by determining the potential role of MIF in the induction of MMP-9 expression in vascular smooth muscle cells (VSMC) and macrophages in vitro. Two-color immunohistochemistry demonstrated that MIF was strongly upregulated by macrophages and VSMCs. This was associated with marked increase in MMP-9 expression in vulnerable atheromatous plaques, but not in the fibrous lesions. Upregulation of MIF and MMP-9 in vulnerable atheromatous plaques was associated with the weakening of fibrous caps. The role of MIF in MMP-9 expression was demonstrated by the ability of MIF to directly induce MMP-9 mRNA and protein expression in macrophages and in VSMCs in a dose and time-dependent manner, which was blocked by a neutralizing MIF antibody. In conclusion, MIF and MMP-9 are markedly upregulated in vulnerable atheromatous plaques. The ability of MIF to induce MMP-9 expression in VSMCs and macrophages suggests that MIF may play a role in the destabilization of human atherosclerotic plaques.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15585220     DOI: 10.1016/j.atherosclerosis.2004.08.030

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  25 in total

1.  Differential roles of cardiac and leukocyte derived macrophage migration inhibitory factor in inflammatory responses and cardiac remodelling post myocardial infarction.

Authors:  David A White; Yidan Su; Peter Kanellakis; Helen Kiriazis; Eric F Morand; Richard Bucala; Anthony M Dart; Xiao-Ming Gao; Xiao-Jun Du
Journal:  J Mol Cell Cardiol       Date:  2014-02-05       Impact factor: 5.000

2.  Exendin-4 ameliorates oxidized-LDL-induced inhibition of macrophage migration in vitro via the NF-κB pathway.

Authors:  Ge-fei Ma; Song Chen; Lei Yin; Xiang-dong Gao; Wen-bing Yao
Journal:  Acta Pharmacol Sin       Date:  2013-12-16       Impact factor: 6.150

3.  MIF produced by bone marrow-derived macrophages contributes to teratoma progression after embryonic stem cell transplantation.

Authors:  Xi Wang; Tianxiang Chen; Lin Leng; Jianqing Fan; Kai Cao; Zhaoxia Duan; Xijing Zhang; Changshun Shao; Mingmei Wu; Iman Tadmori; Tianyi Li; Li Liang; Dongming Sun; Shusen Zheng; Andreas Meinhardt; Wise Young; Richard Bucala; Yi Ren
Journal:  Cancer Res       Date:  2012-03-29       Impact factor: 12.701

4.  Macrophage migration inhibitory factor contributes to host defense against acute Trypanosoma cruzi infection.

Authors:  José L Reyes; Luis I Terrazas; Bertha Espinoza; David Cruz-Robles; Virgilia Soto; Irma Rivera-Montoya; Lorena Gómez-García; Heidi Snider; Abhay R Satoskar; Miriam Rodríguez-Sosa
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

5.  Pro-Inflammatory and Pro-Fibrogenic Effects of Ionic and Particulate Arsenide and Indium-Containing Semiconductor Materials in the Murine Lung.

Authors:  Wen Jiang; Xiang Wang; Olivia J Osborne; Yingjie Du; Chong Hyun Chang; Yu-Pei Liao; Bingbing Sun; Jinhong Jiang; Zhaoxia Ji; Ruibin Li; Xiangsheng Liu; Jianqin Lu; Sijie Lin; Huan Meng; Tian Xia; André E Nel
Journal:  ACS Nano       Date:  2017-02-08       Impact factor: 15.881

6.  Loss of macrophage migration inhibitory factor impairs the growth properties of human HeLa cervical cancer cells.

Authors:  D Z Xiao; B Dai; J Chen; Q Luo; X Y Liu; Q X Lin; X H Li; W Huang; X Y Yu
Journal:  Cell Prolif       Date:  2011-10-13       Impact factor: 6.831

Review 7.  Chemokine-like functions of MIF in atherosclerosis.

Authors:  Andreas Schober; Jürgen Bernhagen; Christian Weber
Journal:  J Mol Med (Berl)       Date:  2008-04-02       Impact factor: 4.599

8.  Regulations of the key mediators in inflammation and atherosclerosis by aspirin in human macrophages.

Authors:  Li Lu; Hong Liu; Jiahe Peng; Lin Gan; Lili Shen; Qian Zhang; Liangpeng Li; Li Zhang; Chang Su; Yu Jiang
Journal:  Lipids Health Dis       Date:  2010-02-06       Impact factor: 3.876

9.  Elevated serum macrophage migration inhibitory factor (MIF) concentrations in chronic kidney disease (CKD) are associated with markers of oxidative stress and endothelial activation.

Authors:  Annette Bruchfeld; Juan J Carrero; Abdul R Qureshi; Bengt Lindholm; Peter Barany; Olof Heimburger; Maowen Hu; Xinchun Lin; Peter Stenvinkel; Edmund J Miller
Journal:  Mol Med       Date:  2009-12-08       Impact factor: 6.354

10.  Angiotensin II is related to the acute aortic dissection complicated with lung injury through mediating the release of MMP9 from macrophages.

Authors:  Zhiyong Wu; Yongle Ruan; Jinxing Chang; Bowen Li; Wei Ren
Journal:  Am J Transl Res       Date:  2016-03-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.